对33 000名退伍军人进行的一项研究发现,尼科蒂纳米德将非蛋白瘤皮肤癌风险降低14%,特别是在肮脏细胞癌方面。 A study of 33,000 veterans finds nicotinamide lowers non-melanoma skin cancer risk by 14%, especially for squamous cell carcinoma.

一项涉及33 000名退伍军人的大型研究将尼古丁胺(一种维生素B3)与非蛋白瘤皮肤癌的总体风险降低14%联系起来,对可口细胞癌的减少幅度超过20%。 A large study of 33,000 veterans links nicotinamide, a form of vitamin B3, to a 14% lower overall risk of non-melanoma skin cancer, with reductions exceeding 20% for squamous cell carcinoma. 虽然在非白人人口或器官移植接受者中尚未确认好处, 但先前的研究发现, 先前皮肤癌患者的风险降低幅度高达50%。 Findings support earlier research showing up to 50% risk reduction in those with prior skin cancer, though benefits haven’t been confirmed in non-white populations or organ transplant recipients. 专家认为,对高风险个人而言,尼丙胺是一种安全、低成本的预防办法,但强调它不应取代防晒。 Experts view nicotinamide as a safe, low-cost preventive option for high-risk individuals, but stress it should not replace sun protection.